Angiotensin type 2 receptor antagonism as a new target to manage gout.
Vieira TN, Saraiva ALL, Guimarães RM, Luiz JPM, Pinto LG, de Melo Rodrigues Ávila V, Goulart LR, Cunha-Junior JP, McNaughton PA, Cunha TM, Ferreira J, Silva CR.
Vieira TN, et al. Among authors: mcnaughton pa.
Inflammopharmacology. 2022 Dec;30(6):2399-2410. doi: 10.1007/s10787-022-01076-x. Epub 2022 Sep 29.
Inflammopharmacology. 2022.
PMID: 36173505
Free PMC article.